# we ventures

> we ventures is a VC fund in Seongnam backing Health Care and Biotechnology. See 14 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seongnam, South Korea
- Total investments: 14
- Last investment: Aug 2023
- Lead investor: 7%
- Last updated: Aug 2026
- Website: http://en.weventures.co.kr/

we ventures is a VC industry with innovative venture capitalists, who invest in creative, honest, and outstanding entrepreneurs.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 21% |
| Biotechnology | 3 | 21% |
| Artificial Intelligence | 3 | 21% |
| Software | 2 | 14% |
| E-Commerce | 2 | 14% |

35 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 36% |
| Series B | 5 | 36% |
| Seed | 4 | 29% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 13 | 93% |
| United States | 1 | 7% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Plcoskin | Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare. They have developed a scaffold that removes the need for cadaver-sourced material used in breast reconstruction surgery, making procedures safer and cheaper. Plcoskin’s scaffolds are made with synthetic PCL, a biodegradable material that iscommonly used to create surgical sutures. Unlike competitors' products that remain in the body for a lifetime, Plcoskin’s PCL scaffolds are absorbed and replaced with the recipient’s own natural tissues, minimizing the possibility of long-term side effects. As they do not contain any dangerous chemicals, they are also 50% safer than cadaver-sourced scaffolds.Costs for reconstructive breast surgery are brought down by 40% to only $3 thousand per breast. Furthermore, much less handling time is required, reducing average surgery durations from an hour and a half to only 30 minutes. The mesh design of the scaffolds mitigates the need for an additional follow-up reconstructive surgery, something that is common when using cadaver-sourced scaffolds.Plcoskin has also developed Youlief, a cosmeceutical product & therapeutic device pipeline that helps fund R&D for their medical devices. Youlief is available in the US, Europe, Taiwan, Singapore and Japan. | $4M | Series B | Aug 31, 2023 |  |
| Bigwave Robotics | Bigwave Robotics is a developer of robotics devices designed to automate processes. | $7.5M | Series A | Mar 31, 2023 |  |
| POSTYPE | POSTYPE is a content open market where anyone can sell and buy digital content. | $7.6M | Series B | Dec 15, 2022 |  |
| 33M2 | 33M2 is a housing rental platform. The company's platform connects tenants looking for a place to stay in Korea for a short period, such as for business trips, studies, and travel, enabling tourists and students with a network of numerous lessees to find rental homes. | $712.3K | Seed | Nov 04, 2022 |  |
| Disquiet | Disquiet is a space for makers. | $351.1K | Seed | Nov 02, 2022 |  |
| Infomining | Infomining is a digital healthcare platform for medical institutions and governments. | $4M | Series A | Sep 16, 2022 |  |
| Bobidi | Bobidi helps AI companies test and validate their models in the real world very fast and improve them 10x more efficiently. The underlying magic is that they run a global gamified community that is incentivized to test and find the edge cases that the model missed. The whole process would be up to 10x more efficient than the industry norm thattakes as long as a couple of months. | $5.7M | Seed | Jul 14, 2022 |  |
| Shipda | Shipda provides logistics and matching services. | $5M | Series A | May 03, 2022 |  |
| BnH Research | BnH Research develops therapeutics for patients suffering from chronic conditions. | $9.9M | Series B | Mar 18, 2022 |  |
| AiV | AiV is a technology company focused on developing advanced AI and deep learning solutions for industrial applications. It specializes in computer vision systems used for automation, inspection, and smart manufacturing processes. The company aims to improve industrial efficiency by combining AI software, data analytics, and machine learningtechnologies. | $4.4M | Series A | Jun 24, 2021 |  |

10 of 14 investments shown.

## Co-investors
- [We Ventures](https://shizune.co/investors/profile/we-ventures-40c2) — VC Fund, 14 deals together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 5 deals together
- [Shinhan Venture Investment](https://shizune.co/investors/profile/shinhan-venture-investment) — VC Fund, 3 deals together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-investment) — VC Fund, 2 deals together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-partners) — VC Fund, 2 deals together
- [ZER01NE](https://shizune.co/investors/profile/zer01ne) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Marketplace VC Funds in South Korea](https://shizune.co/investors/marketplace-vc-funds-south-korea)
- [Marketplace Investors in South Korea](https://shizune.co/investors/marketplace-investors-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Climate Investors in South Korea](https://shizune.co/investors/climate-investors-south-korea)
- [Climate VC Funds in South Korea](https://shizune.co/investors/climate-vc-funds-south-korea)

## FAQ

### What does we ventures invest in?

we ventures invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 14 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did we ventures last invest?

The most recent investment recorded for we ventures closed in Aug 2023. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co